Title
Category
Credits
Event date
Cost
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain
  • Prescribing: Opioid(s)
  • Pain Management: Opioid(s)
  • Pain Management
  • 3.00 AANP Contact Hours
  • 3.00 AAPA Category I CME
  • 3.00 AMA PRA Category 1 Credit™
$22.00
Pain, in particular chronic pain, continues to impact physical functioning, mental health, and reduced quality of life, and is the leading cause of disability in the United States, leading to updated practice guidelines for prescribing opioids for pain. In addition, federal and state laws continue to evolve to support safe pain management practices and safe opioid prescribing practices, while prescriptive authority of various practitioners is expanding.
CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids for Pain (Web Based) - WB4701
  • Prescribing: Opioid(s)
  • Pain Management: Opioid(s)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
$0.00
This module provides an overview of the 2022 Clinical Practice Guideline recommendations intended for clinicians providing pain care, including those prescribing opioids for outpatients with acute, subacute, and chronic pain. You will learn how to apply the recommendations as flexible standards of care to enable patient-centered decision-making, taking into account an individual’s well-being and what may be expected to happen based on their health or medical conditions.WB4701
Clinical Practice Guidelines for Prescribing Opioids for Pain and Best Practices for Managing Acute Pain
  • Prescribing: Opioid(s)
  • Pain Management: Opioid(s)
  • Pain Management: Acute
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This lecture provides medical professionals with clinical practice guidelines based on the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain. Key topics include: clarification of misapplications from prior CDC opioid prescribing guidelines, highlights health disparities related to pain, considerations of opioids or non-opioid alternative medications, general recommendations for opioid prescribing and continuation of opioid therapy.